As a potential tumor suppressor, DACH1 promoted hypermethylation and correspondingly reduced expression of DACH1 was observed in several kinds of cancers, including esophageal cancer, gastric cancer, colorectal cancer and hepatocellular carcinoma [20,22,31,32]. This evidence concerns the gene DACH1 and esophageal cancer.